0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global α4β7 Integrin Antagonists Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-14Y18484
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global α4β7 Integrin Antagonists Market Research Report 2024
BUY CHAPTERS

Global α4β7 Integrin Antagonists Market Research Report 2026

Code: QYRE-Auto-14Y18484
Report
2026-02-10
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

α4β7 Integrin Antagonists Market Size

The global α4β7 Integrin Antagonists market was valued at US$ 10060 million in 2025 and is anticipated to reach US$ 18710 million by 2032, at a CAGR of 9.4% from 2026 to 2032.

α4β7 Integrin Antagonists Market

α4β7 Integrin Antagonists Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on α4β7 Integrin Antagonists competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
α4β7 integrin antagonists are a class of therapeutic agents that specifically target the α4β7 integrin, a receptor expressed on lymphocytes that plays a crucial role in the homing of these immune cells to the gut. By inhibiting this integrin, these drugs prevent lymphocytes from migrating to inflamed intestinal tissues, making them particularly effective in treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
The North American market for α4β7 Integrin Antagonists is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for α4β7 Integrin Antagonists is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of α4β7 Integrin Antagonists include Takeda, Biogen, Sandoz, Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global α4β7 Integrin Antagonists market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding α4β7 Integrin Antagonists. The α4β7 Integrin Antagonists market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global α4β7 Integrin Antagonists market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist α4β7 Integrin Antagonists manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of α4β7 Integrin Antagonists Market Report

Report Metric Details
Report Name α4β7 Integrin Antagonists Market
Accounted market size in 2025 US$ 10060 million
Forecasted market size in 2032 US$ 18710 million
CAGR 9.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Natalizumub
  • Vedolizumab
by Application
  • Inflammatory Bowel Disease (IBD)
  • Multiple Sclerosis (MS)
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda, Biogen, Sandoz, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for α4β7 Integrin Antagonists manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines α4β7 Integrin Antagonists sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is α4β7 Integrin Antagonists Market growing?

Ans: The α4β7 Integrin Antagonists Market witnessing a CAGR of 9.4% during the forecast period 2026-2032.

What is the α4β7 Integrin Antagonists Market size in 2032?

Ans: The α4β7 Integrin Antagonists Market size in 2032 will be US$ 18710 million.

Who are the main players in the α4β7 Integrin Antagonists Market report?

Ans: The main players in the α4β7 Integrin Antagonists Market are Takeda, Biogen, Sandoz, Novartis

What are the Application segmentation covered in the α4β7 Integrin Antagonists Market report?

Ans: The Applications covered in the α4β7 Integrin Antagonists Market report are Inflammatory Bowel Disease (IBD), Multiple Sclerosis (MS), Other

What are the Type segmentation covered in the α4β7 Integrin Antagonists Market report?

Ans: The Types covered in the α4β7 Integrin Antagonists Market report are Natalizumub, Vedolizumab

1 α4β7 Integrin Antagonists Market Overview
1.1 Product Definition
1.2 α4β7 Integrin Antagonists by Type
1.2.1 Global α4β7 Integrin Antagonists Market Value by Type: 2025 vs 2032
1.2.2 Natalizumub
1.2.3 Vedolizumab
1.3 α4β7 Integrin Antagonists by Application
1.3.1 Global α4β7 Integrin Antagonists Market Value by Application: 2025 vs 2032
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Multiple Sclerosis (MS)
1.3.4 Other
1.4 Global α4β7 Integrin Antagonists Market Size Estimates and Forecasts
1.4.1 Global α4β7 Integrin Antagonists Revenue 2021–2032
1.4.2 Global α4β7 Integrin Antagonists Sales 2021–2032
1.4.3 Global α4β7 Integrin Antagonists Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 α4β7 Integrin Antagonists Market Competition by Manufacturers
2.1 Global α4β7 Integrin Antagonists Sales Market Share by Manufacturers (2021–2026)
2.2 Global α4β7 Integrin Antagonists Revenue Market Share by Manufacturers (2021–2026)
2.3 Global α4β7 Integrin Antagonists Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of α4β7 Integrin Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of α4β7 Integrin Antagonists, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of α4β7 Integrin Antagonists, Product Types and Applications
2.7 Global Key Manufacturers of α4β7 Integrin Antagonists, Date of Entry into the Industry
2.8 Global α4β7 Integrin Antagonists Market Competitive Situation and Trends
2.8.1 Global α4β7 Integrin Antagonists Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global α4β7 Integrin Antagonists Players Market Share by Revenue
2.8.3 Global α4β7 Integrin Antagonists Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global α4β7 Integrin Antagonists Market Scenario by Region
3.1 Global α4β7 Integrin Antagonists Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global α4β7 Integrin Antagonists Sales by Region: 2021–2032
3.2.1 Global α4β7 Integrin Antagonists Sales by Region: 2021–2026
3.2.2 Global α4β7 Integrin Antagonists Sales by Region: 2027–2032
3.3 Global α4β7 Integrin Antagonists Revenue by Region: 2021–2032
3.3.1 Global α4β7 Integrin Antagonists Revenue by Region: 2021–2026
3.3.2 Global α4β7 Integrin Antagonists Revenue by Region: 2027–2032
3.4 North America α4β7 Integrin Antagonists Market Facts & Figures by Country
3.4.1 North America α4β7 Integrin Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America α4β7 Integrin Antagonists Sales by Country (2021–2032)
3.4.3 North America α4β7 Integrin Antagonists Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe α4β7 Integrin Antagonists Market Facts & Figures by Country
3.5.1 Europe α4β7 Integrin Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe α4β7 Integrin Antagonists Sales by Country (2021–2032)
3.5.3 Europe α4β7 Integrin Antagonists Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific α4β7 Integrin Antagonists Market Facts & Figures by Region
3.6.1 Asia Pacific α4β7 Integrin Antagonists Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific α4β7 Integrin Antagonists Sales by Region (2021–2032)
3.6.3 Asia Pacific α4β7 Integrin Antagonists Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America α4β7 Integrin Antagonists Market Facts & Figures by Country
3.7.1 Latin America α4β7 Integrin Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America α4β7 Integrin Antagonists Sales by Country (2021–2032)
3.7.3 Latin America α4β7 Integrin Antagonists Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa α4β7 Integrin Antagonists Market Facts & Figures by Country
3.8.1 Middle East and Africa α4β7 Integrin Antagonists Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa α4β7 Integrin Antagonists Sales by Country (2021–2032)
3.8.3 Middle East and Africa α4β7 Integrin Antagonists Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global α4β7 Integrin Antagonists Sales by Type (2021–2032)
4.1.1 Global α4β7 Integrin Antagonists Sales by Type (2021–2026)
4.1.2 Global α4β7 Integrin Antagonists Sales by Type (2027–2032)
4.1.3 Global α4β7 Integrin Antagonists Sales Market Share by Type (2021–2032)
4.2 Global α4β7 Integrin Antagonists Revenue by Type (2021–2032)
4.2.1 Global α4β7 Integrin Antagonists Revenue by Type (2021–2026)
4.2.2 Global α4β7 Integrin Antagonists Revenue by Type (2027–2032)
4.2.3 Global α4β7 Integrin Antagonists Revenue Market Share by Type (2021–2032)
4.3 Global α4β7 Integrin Antagonists Price by Type (2021–2032)
5 Segment by Application
5.1 Global α4β7 Integrin Antagonists Sales by Application (2021–2032)
5.1.1 Global α4β7 Integrin Antagonists Sales by Application (2021–2026)
5.1.2 Global α4β7 Integrin Antagonists Sales by Application (2027–2032)
5.1.3 Global α4β7 Integrin Antagonists Sales Market Share by Application (2021–2032)
5.2 Global α4β7 Integrin Antagonists Revenue by Application (2021–2032)
5.2.1 Global α4β7 Integrin Antagonists Revenue by Application (2021–2026)
5.2.2 Global α4β7 Integrin Antagonists Revenue by Application (2027–2032)
5.2.3 Global α4β7 Integrin Antagonists Revenue Market Share by Application (2021–2032)
5.3 Global α4β7 Integrin Antagonists Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Company Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda α4β7 Integrin Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Takeda α4β7 Integrin Antagonists Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Biogen
6.2.1 Biogen Company Information
6.2.2 Biogen Description and Business Overview
6.2.3 Biogen α4β7 Integrin Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Biogen α4β7 Integrin Antagonists Product Portfolio
6.2.5 Biogen Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Company Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz α4β7 Integrin Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sandoz α4β7 Integrin Antagonists Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis α4β7 Integrin Antagonists Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novartis α4β7 Integrin Antagonists Product Portfolio
6.4.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 α4β7 Integrin Antagonists Industry Chain Analysis
7.2 α4β7 Integrin Antagonists Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 α4β7 Integrin Antagonists Production Mode & Process Analysis
7.4 α4β7 Integrin Antagonists Sales and Marketing
7.4.1 α4β7 Integrin Antagonists Sales Channels
7.4.2 α4β7 Integrin Antagonists Distributors
7.5 α4β7 Integrin Antagonists Customer Analysis
8 α4β7 Integrin Antagonists Market Dynamics
8.1 α4β7 Integrin Antagonists Industry Trends
8.2 α4β7 Integrin Antagonists Market Drivers
8.3 α4β7 Integrin Antagonists Market Challenges
8.4 α4β7 Integrin Antagonists Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global α4β7 Integrin Antagonists Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global α4β7 Integrin Antagonists Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global α4β7 Integrin Antagonists Market Competitive Situation by Manufacturers in 2025
 Table 4. Global α4β7 Integrin Antagonists Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global α4β7 Integrin Antagonists Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global α4β7 Integrin Antagonists Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market α4β7 Integrin Antagonists Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of α4β7 Integrin Antagonists, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of α4β7 Integrin Antagonists, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of α4β7 Integrin Antagonists, Product Types and Applications
 Table 12. Global Key Manufacturers of α4β7 Integrin Antagonists, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global α4β7 Integrin Antagonists Companies by Tier (Tier 1, Tier 2, Tier 3), based on α4β7 Integrin Antagonists Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global α4β7 Integrin Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global α4β7 Integrin Antagonists Sales by Region (K Units), 2021–2026
 Table 18. Global α4β7 Integrin Antagonists Sales Market Share by Region (2021–2026)
 Table 19. Global α4β7 Integrin Antagonists Sales by Region (K Units), 2027–2032
 Table 20. Global α4β7 Integrin Antagonists Sales Market Share by Region (2027–2032)
 Table 21. Global α4β7 Integrin Antagonists Revenue by Region (US$ Million), 2021–2026
 Table 22. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2021–2026)
 Table 23. Global α4β7 Integrin Antagonists Revenue by Region (US$ Million), 2027–2032
 Table 24. Global α4β7 Integrin Antagonists Revenue Market Share by Region (2027–2032)
 Table 25. North America α4β7 Integrin Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America α4β7 Integrin Antagonists Sales by Country (K Units), 2021–2026
 Table 27. North America α4β7 Integrin Antagonists Sales by Country (K Units), 2027–2032
 Table 28. North America α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 29. North America α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe α4β7 Integrin Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe α4β7 Integrin Antagonists Sales by Country (K Units), 2021–2026
 Table 32. Europe α4β7 Integrin Antagonists Sales by Country (K Units), 2027–2032
 Table 33. Europe α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific α4β7 Integrin Antagonists Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific α4β7 Integrin Antagonists Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific α4β7 Integrin Antagonists Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific α4β7 Integrin Antagonists Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific α4β7 Integrin Antagonists Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America α4β7 Integrin Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America α4β7 Integrin Antagonists Sales by Country (K Units), 2021–2026
 Table 42. Latin America α4β7 Integrin Antagonists Sales by Country (K Units), 2027–2032
 Table 43. Latin America α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa α4β7 Integrin Antagonists Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa α4β7 Integrin Antagonists Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa α4β7 Integrin Antagonists Revenue by Country (US$ Million), 2027–2032
 Table 50. Global α4β7 Integrin Antagonists Sales (K Units) by Type (2021–2026)
 Table 51. Global α4β7 Integrin Antagonists Sales (K Units) by Type (2027–2032)
 Table 52. Global α4β7 Integrin Antagonists Sales Market Share by Type (2021–2026)
 Table 53. Global α4β7 Integrin Antagonists Sales Market Share by Type (2027–2032)
 Table 54. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2021–2026)
 Table 57. Global α4β7 Integrin Antagonists Revenue Market Share by Type (2027–2032)
 Table 58. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2021–2026)
 Table 59. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2027–2032)
 Table 60. Global α4β7 Integrin Antagonists Sales (K Units) by Application (2021–2026)
 Table 61. Global α4β7 Integrin Antagonists Sales (K Units) by Application (2027–2032)
 Table 62. Global α4β7 Integrin Antagonists Sales Market Share by Application (2021–2026)
 Table 63. Global α4β7 Integrin Antagonists Sales Market Share by Application (2027–2032)
 Table 64. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global α4β7 Integrin Antagonists Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2021–2026)
 Table 67. Global α4β7 Integrin Antagonists Revenue Market Share by Application (2027–2032)
 Table 68. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2021–2026)
 Table 69. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2027–2032)
 Table 70. Takeda Company Information
 Table 71. Takeda Description and Business Overview
 Table 72. Takeda α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Takeda α4β7 Integrin Antagonists Product
 Table 74. Takeda Recent Developments/Updates
 Table 75. Biogen Company Information
 Table 76. Biogen Description and Business Overview
 Table 77. Biogen α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Biogen α4β7 Integrin Antagonists Product
 Table 79. Biogen Recent Developments/Updates
 Table 80. Sandoz Company Information
 Table 81. Sandoz Description and Business Overview
 Table 82. Sandoz α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Sandoz α4β7 Integrin Antagonists Product
 Table 84. Sandoz Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis α4β7 Integrin Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Novartis α4β7 Integrin Antagonists Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. α4β7 Integrin Antagonists Distributors List
 Table 93. α4β7 Integrin Antagonists Customers List
 Table 94. α4β7 Integrin Antagonists Market Trends
 Table 95. α4β7 Integrin Antagonists Market Drivers
 Table 96. α4β7 Integrin Antagonists Market Challenges
 Table 97. α4β7 Integrin Antagonists Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of α4β7 Integrin Antagonists
 Figure 2. Global α4β7 Integrin Antagonists Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global α4β7 Integrin Antagonists Market Share by Type: 2025 & 2032
 Figure 4. Natalizumub Product Picture
 Figure 5. Vedolizumab Product Picture
 Figure 6. Global α4β7 Integrin Antagonists Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global α4β7 Integrin Antagonists Market Share by Application: 2025 & 2032
 Figure 8. Inflammatory Bowel Disease (IBD)
 Figure 9. Multiple Sclerosis (MS)
 Figure 10. Other
 Figure 11. Global α4β7 Integrin Antagonists Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global α4β7 Integrin Antagonists Market Size (US$ Million), 2021–2032
 Figure 13. Global α4β7 Integrin Antagonists Sales (K Units), 2021–2032
 Figure 14. Global α4β7 Integrin Antagonists Average Price (US$/Unit), 2021–2032
 Figure 15. α4β7 Integrin Antagonists Report Years Considered
 Figure 16. α4β7 Integrin Antagonists Sales Share by Manufacturers in 2025
 Figure 17. Global α4β7 Integrin Antagonists Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global α4β7 Integrin Antagonists Players: Market Share by Revenue in α4β7 Integrin Antagonists in 2025
 Figure 19. α4β7 Integrin Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global α4β7 Integrin Antagonists Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America α4β7 Integrin Antagonists Sales Market Share by Country (2021–2032)
 Figure 22. North America α4β7 Integrin Antagonists Revenue Market Share by Country (2021–2032)
 Figure 23. United States α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe α4β7 Integrin Antagonists Sales Market Share by Country (2021–2032)
 Figure 26. Europe α4β7 Integrin Antagonists Revenue Market Share by Country (2021–2032)
 Figure 27. Germany α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific α4β7 Integrin Antagonists Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific α4β7 Integrin Antagonists Revenue Market Share by Region (2021–2032)
 Figure 34. China α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America α4β7 Integrin Antagonists Sales Market Share by Country (2021–2032)
 Figure 42. Latin America α4β7 Integrin Antagonists Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa α4β7 Integrin Antagonists Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa α4β7 Integrin Antagonists Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE α4β7 Integrin Antagonists Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of α4β7 Integrin Antagonists by Type (2021–2032)
 Figure 53. Global Revenue Market Share of α4β7 Integrin Antagonists by Type (2021–2032)
 Figure 54. Global α4β7 Integrin Antagonists Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of α4β7 Integrin Antagonists by Application (2021–2032)
 Figure 56. Global Revenue Market Share of α4β7 Integrin Antagonists by Application (2021–2032)
 Figure 57. Global α4β7 Integrin Antagonists Price (US$/Unit) by Application (2021–2032)
 Figure 58. α4β7 Integrin Antagonists Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners